An intriguing and hitherto unexplained co-occurrence: Depression and chronic fatigue syndrome are manifestations of shared inflammatory, oxidative and nitrosative (IO&NS) pathways. — CFSMEATLAS
An intriguing and hitherto unexplained co-occurrence: Depression and chronic fatigue syndrome are manifestations of shared inflammatory, oxidative and nitrosative (IO&NS) pathways.
Maes, Michael · Progress in neuro-psychopharmacology & biological psychiatry · 2011 · DOI
Quick Summary
Depression and ME/CFS often occur together, and this study suggests they share common biological root causes involving inflammation and oxidative stress (damage to cells). While depression and ME/CFS look different clinically, they appear to involve similar underlying problems with the immune system, energy production, and antioxidant defenses. The authors argue these should be considered connected disorders rather than two separate conditions that happen to co-occur.
Why It Matters
This framework helps explain why many ME/CFS patients experience depression as a disease feature rather than a psychological reaction. Understanding shared biological mechanisms could lead to targeted treatments addressing the underlying inflammation and oxidative stress rather than treating depression and fatigue as separate problems. This perspective validates that both conditions involve real physiological dysfunction.
Observed Findings
Depression and ME/CFS share aberrations in inflammatory pathways, including elevated systemic inflammation and oxidative/nitrosative (O&NS) damage to lipids, proteins, and DNA.
Both conditions show mitochondrial dysfunction, lowered antioxidant levels (zinc, CoQ10), and reduced omega-3 polyunsaturated fatty acid levels.
Autoimmune responses to neoepitopes formed by oxidative/nitrosative damage occur in both disorders.
Increased translocation of gram-negative bacteria is present in both conditions.
Pathway-specific markers exist: indoleamine 2,3-dioxygenase and neurodegeneration characterize depression, while 2'-5' oligoadenylate synthetase/RNase L pathway activation characterizes ME/CFS.
Inferred Conclusions
Depression and ME/CFS should be reclassified as 'co-associated disorders' sharing common IO&NS pathways rather than as separate 'comorbid' conditions.
Current animal models of depression induced by cytokines reflect sickness behavior rather than true human depression or ME/CFS, limiting their translational value.
The shared biological underpinnings of depression and ME/CFS support a pathophysiology-based rather than symptom-based approach to understanding their relationship.
Remaining Questions
Which IO&NS abnormalities are primary drivers versus secondary consequences in each condition?
What This Study Does Not Prove
This review does not prove that inflammation and oxidative stress definitively cause either condition—it identifies associations that may be correlational or secondary effects. It does not provide new experimental evidence, only synthesizes existing studies. The proposed distinction between 'sickness behavior,' depression, and ME/CFS remains theoretical and would require prospective studies to confirm.